Cargando…
Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol
BACKGROUND: Both dexamethasone and betamethasone, given to women at risk of preterm birth, substantially improve short-term neonatal health, increase the chance of the baby being discharged home alive, and reduce childhood neurosensory disability, remaining safe into adulthood. However, it is unclea...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655914/ https://www.ncbi.nlm.nih.gov/pubmed/23642125 http://dx.doi.org/10.1186/1471-2393-13-104 |
_version_ | 1782269946878754816 |
---|---|
author | Crowther, Caroline A Harding, Jane E Middleton, Philippa F Andersen, Chad C Ashwood, Pat Robinson, Jeffrey S |
author_facet | Crowther, Caroline A Harding, Jane E Middleton, Philippa F Andersen, Chad C Ashwood, Pat Robinson, Jeffrey S |
author_sort | Crowther, Caroline A |
collection | PubMed |
description | BACKGROUND: Both dexamethasone and betamethasone, given to women at risk of preterm birth, substantially improve short-term neonatal health, increase the chance of the baby being discharged home alive, and reduce childhood neurosensory disability, remaining safe into adulthood. However, it is unclear which corticosteroid is of greater benefit to mother and child. This study aims to determine whether giving dexamethasone to women at risk of preterm birth at less than 34 weeks’ gestation increases the chance of their children surviving free of neurosensory disability at two years’ corrected age, compared with betamethasone. METHODS/DESIGN: Design randomised, multicentre, placebo controlled trial. Inclusion criteria women at risk of preterm birth at less than 34 weeks’ gestation with a singleton or twin pregnancy and no contraindications to the use of antenatal corticosteroids and who give informed consent. Trial entry & randomisation at telephone randomisation eligible women will be randomly allocated to either the dexamethasone group or the betamethasone group, allocated a study number and corresponding treatment pack. Study groups women in the dexamethasone group will be administered two syringes of 12 mg dexamethasone (dexamethasone sodium phosphate) and women in the betamethasone group will be administered two syringes of 11.4 mg betamethasone (Celestone Chronodose). Both study groups consist of intramuscular treatments 24 hours apart. Primary study outcome death or any neurosensory disability measured in children at two years’ corrected age. Sample size a sample size of 1449 children is required to detect either a decrease in death or any neurosensory disability from 27.0% to 20.1% with dexamethasone compared with betamethasone, or an increase from 27.0% to 34.5% (two-sided alpha 0.05, 80% power, 5% loss to follow up, design effect 1.2). DISCUSSION: This study will provide high-level evidence of direct relevance for clinical practice. If one drug clearly results in significantly fewer deaths and fewer disabled children then it should be used consistently in women at risk of preterm birth and would be of great importance to women at risk of preterm birth, their children, health services and communities. TRIAL REGISTRATION: Trial registration number: ACTRN12608000631303 |
format | Online Article Text |
id | pubmed-3655914 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36559142013-05-17 Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol Crowther, Caroline A Harding, Jane E Middleton, Philippa F Andersen, Chad C Ashwood, Pat Robinson, Jeffrey S BMC Pregnancy Childbirth Study Protocol BACKGROUND: Both dexamethasone and betamethasone, given to women at risk of preterm birth, substantially improve short-term neonatal health, increase the chance of the baby being discharged home alive, and reduce childhood neurosensory disability, remaining safe into adulthood. However, it is unclear which corticosteroid is of greater benefit to mother and child. This study aims to determine whether giving dexamethasone to women at risk of preterm birth at less than 34 weeks’ gestation increases the chance of their children surviving free of neurosensory disability at two years’ corrected age, compared with betamethasone. METHODS/DESIGN: Design randomised, multicentre, placebo controlled trial. Inclusion criteria women at risk of preterm birth at less than 34 weeks’ gestation with a singleton or twin pregnancy and no contraindications to the use of antenatal corticosteroids and who give informed consent. Trial entry & randomisation at telephone randomisation eligible women will be randomly allocated to either the dexamethasone group or the betamethasone group, allocated a study number and corresponding treatment pack. Study groups women in the dexamethasone group will be administered two syringes of 12 mg dexamethasone (dexamethasone sodium phosphate) and women in the betamethasone group will be administered two syringes of 11.4 mg betamethasone (Celestone Chronodose). Both study groups consist of intramuscular treatments 24 hours apart. Primary study outcome death or any neurosensory disability measured in children at two years’ corrected age. Sample size a sample size of 1449 children is required to detect either a decrease in death or any neurosensory disability from 27.0% to 20.1% with dexamethasone compared with betamethasone, or an increase from 27.0% to 34.5% (two-sided alpha 0.05, 80% power, 5% loss to follow up, design effect 1.2). DISCUSSION: This study will provide high-level evidence of direct relevance for clinical practice. If one drug clearly results in significantly fewer deaths and fewer disabled children then it should be used consistently in women at risk of preterm birth and would be of great importance to women at risk of preterm birth, their children, health services and communities. TRIAL REGISTRATION: Trial registration number: ACTRN12608000631303 BioMed Central 2013-05-03 /pmc/articles/PMC3655914/ /pubmed/23642125 http://dx.doi.org/10.1186/1471-2393-13-104 Text en Copyright © 2013 Crowther et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Crowther, Caroline A Harding, Jane E Middleton, Philippa F Andersen, Chad C Ashwood, Pat Robinson, Jeffrey S Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol |
title | Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol |
title_full | Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol |
title_fullStr | Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol |
title_full_unstemmed | Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol |
title_short | Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol |
title_sort | australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (a*steroid): study protocol |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655914/ https://www.ncbi.nlm.nih.gov/pubmed/23642125 http://dx.doi.org/10.1186/1471-2393-13-104 |
work_keys_str_mv | AT crowthercarolinea australasianrandomisedtrialtoevaluatetheroleofmaternalintramusculardexamethasoneversusbetamethasonepriortopretermbirthtoincreasesurvivalfreeofchildhoodneurosensorydisabilityasteroidstudyprotocol AT hardingjanee australasianrandomisedtrialtoevaluatetheroleofmaternalintramusculardexamethasoneversusbetamethasonepriortopretermbirthtoincreasesurvivalfreeofchildhoodneurosensorydisabilityasteroidstudyprotocol AT middletonphilippaf australasianrandomisedtrialtoevaluatetheroleofmaternalintramusculardexamethasoneversusbetamethasonepriortopretermbirthtoincreasesurvivalfreeofchildhoodneurosensorydisabilityasteroidstudyprotocol AT andersenchadc australasianrandomisedtrialtoevaluatetheroleofmaternalintramusculardexamethasoneversusbetamethasonepriortopretermbirthtoincreasesurvivalfreeofchildhoodneurosensorydisabilityasteroidstudyprotocol AT ashwoodpat australasianrandomisedtrialtoevaluatetheroleofmaternalintramusculardexamethasoneversusbetamethasonepriortopretermbirthtoincreasesurvivalfreeofchildhoodneurosensorydisabilityasteroidstudyprotocol AT robinsonjeffreys australasianrandomisedtrialtoevaluatetheroleofmaternalintramusculardexamethasoneversusbetamethasonepriortopretermbirthtoincreasesurvivalfreeofchildhoodneurosensorydisabilityasteroidstudyprotocol |